HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Necrobiosis lipoidica occurring in a patient with rheumatoid arthritis on concurrent tumor necrosis factor-α inhibitor therapy.

AuthorsCatherine G Chung, Abric Rosengrant, Klaus F Helm, David L Shupp
JournalInternational journal of dermatology (Int J Dermatol) Vol. 54 Issue 11 Pg. 1294-6 (Nov 2015) ISSN: 1365-4632 [Electronic] England
PMID24697547 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Adalimumab
  • Prednisone
  • Methotrexate
Topics
  • Adalimumab (therapeutic use)
  • Arthritis, Rheumatoid (complications, drug therapy)
  • Female
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Leg Dermatoses (complications, pathology)
  • Methotrexate (therapeutic use)
  • Necrobiosis Lipoidica (complications, pathology)
  • Prednisone (therapeutic use)
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: